Future gazing in the management of multiply drug-resistant Gram-positive infection

Mark H Wilcox1

  • 1Department of Microbiology, Leeds Teaching Hospitals NHS Trust and Institute of Molecular and Cellular Biology, University of Leeds, Leeds, UK. Mark.Wilcox@leedsth.nhs.uk

The Journal of Infection
|September 22, 2009
PubMed

Insights

Gram-positive bacteria are a growing threat in healthcare settings. New antibiotic strategies and infection control methods are crucial to combat these resistant pathogens, particularly methicillin-resistant staphylococci.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Antimicrobial Resistance

Background:

  • Gram-positive bacteria are increasingly prevalent in healthcare-associated infections.
  • The rise of antimicrobial resistance poses a significant challenge to public health.
  • Methicillin-resistant staphylococci represent a critical area of concern.

Purpose of the Study:

  • To review the challenges posed by Gram-positive pathogens in healthcare settings.
  • To discuss novel approaches for antibiotic development and control.
  • To explore additional infection control strategies.

Main Methods:

  • Literature review of current research on Gram-positive pathogens.
  • Analysis of antibiotic resistance mechanisms.
  • Discussion of emerging therapeutic and preventative strategies.

Main Results:

  • Gram-positive bacteria are a major cause of healthcare-associated infections.
  • Existing antibiotics face challenges due to evolving resistance.
  • Novel strategies are needed for effective treatment and control.

Conclusions:

  • Urgent need for innovative antibiotic development and prescribing practices.
  • Enhanced infection control measures are essential.
  • Addressing methicillin-resistant staphylococci requires a multi-faceted approach.

Related Concept Videos

Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...